Spruce Biosciences

Spruce Biosciences: Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years. Spruce is also developing tildacerfont for women suffering from a rare form of polycystic ovary syndrome (PCOS) with primary adrenal androgen excess.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Clinical Stage
Phase III, Phase l or ll
Disease Space
Metabolic Disorders, Rare Disease
Listing
Public, USA
Market Cap
<100MM
Website:
Profiles:
Address:
611 Gateway Boulevard, Suite 740
South San Francisco, CA 94080
United States

Company Participants at Solebury 1x1 Management Access Event 2023

  • Javier Szwarcberg, CEO

Upcoming Company Event Participation

Top 10 Holders of Spruce Biosciences, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Novo Holdings A/S 19.16 4,514,336 4.92 13F 9/30/22
Omega Fund Management LLC 9.17 2,161,022 2.36 13F 9/30/22
RiverVest Venture Management LLC 9.12 2,148,281 2.34 13F 9/30/22
Abingworth LLP 7.61 1,792,518 1.95 13F 9/30/22
Citadel Advisors LLC (13f Subfiler) 7.21 1,698,618 1.85 13F 9/30/22
Rock Springs Capital Management LP 6.89 1,622,689 1.77 13F 9/30/22
Aisling Capital Management LP 5.12 1,205,511 1.31 13F 9/30/22
Logos Global Management LP 4.24 1,000,000 1.09 13F 9/30/22
Sands Capital Ventures LLC 3.34 787,007 0.86 13F 9/30/22
Millennium Management LLC 0.62 145,015 0.16 13F 9/30/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.